Research programme: G protein-coupled receptor modulators - TheratechnologiesAlternative Names: GPCR modulators - Theratechnologies; TH 2701
Latest Information Update: 10 Jan 2007
At a glance
- Originator Theratechnologies
- Mechanism of Action G protein-coupled receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetes mellitus